A rational approach to dose optimisation of pembrolizumab and nivolumab using cost analysis and pharmacokinetic modelling and simulation

K. Ogungbenro, A. Patel, R. Duncombe, J. Clark, P. Lorigan

Research output: Contribution to journal › Article › peer-review

Research Beacons, Institutes and Platforms

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{2e9f1a242c9a4e71974cc4e6d3c00587,

title = "A rational approach to dose optimisation of pembrolizumab and nivolumab using cost analysis and pharmacokinetic modelling and simulation",

author = "K. Ogungbenro and A. Patel and R. Duncombe and J. Clark and P. Lorigan",

year = "2016",

month = oct,

doi = "10.1093/annonc/mdw378.36",

language = "English",

volume = "27",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier BV",

number = "suppl_6",

}

TY - JOUR

T1 - A rational approach to dose optimisation of pembrolizumab and nivolumab using cost analysis and pharmacokinetic modelling and simulation

AU - Ogungbenro, K.

AU - Patel, A.

AU - Duncombe, R.

AU - Clark, J.

AU - Lorigan, P.

PY - 2016/10

Y1 - 2016/10

U2 - 10.1093/annonc/mdw378.36

DO - 10.1093/annonc/mdw378.36

M3 - Article

SN - 0923-7534

VL - 27

JO - Annals of Oncology

JF - Annals of Oncology

IS - suppl_6

ER -